JohnFO'TooleMD

Assistant Professor, Medicine, Case Western Reserve University School of Medicine

Dr. O'Toole is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2500 Metrohealth Dr
# Rammelka
Cleveland, OH 44109
Phone+1 216-778-5790

Fax+1 216-778-2338

University of MichiganFellowship, Nephrology, 2001 - 2003
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1998 - 2001
University of Cincinnati College of MedicineClass of 1998

MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
Completed
Phase 2, Phase 3

PubMed

69 citations
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
Laura H. Mariani, Andrew S. Bomback, Pietro A. Canetta, Michael F. Flessner, Margaret E. Helmuth
American Journal of Kidney Diseases. 2019-02-01
24 citations
Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis.
Insa M. Schmidt, Mia R. Colona, Bryan Kestenbaum, Leonidas G. Alexopoulos, Ragnar Palsson
Kidney International. 2021-09-01
461 citations
Mapping the NPHP-JBTS-MKS Protein Network Reveals Ciliopathy Disease Genes and Pathways
Liyun Sang, Julie J. Miller, Kevin C. Corbit, Rachel H. Giles, Matthew J. Brauer
Cell. 2011-05-13

The Biology Of Genetic Variants In Human Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2011
Functional Characterization Of The Novel Protein Nephrocystin-5National Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
Functional Characterization Of The Novel Protein Nephrocystin-5National Institute Of Diabetes And Digestive And Kidney Diseases2006–2007